CASI completes enrollment in Phase II of ENMD-2076 for TNBC

In April, CASI Pharmaceuticals Inc. (NASDAQ:CASI) completed enrollment of 41

Read the full 109 word article

How to gain access

Continue reading with a
two-week free trial.